Toxicity from asparaginase during acute lymphoblastic leukemia induction: a report from the Children's Oncology Group.
Saved in:
| Title: | Toxicity from asparaginase during acute lymphoblastic leukemia induction: a report from the Children's Oncology Group. |
|---|---|
| Authors: | Orgel E; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA.; Keck School of Medicine, University of Southern California, Los Angeles, CA., Maese LD; Huntsman Cancer Institute, Primary Children's Hospital, University of Utah, Salt Lake City, UT., Devidas M; St Jude Children's Research Hospital, Memphis, TN., Militano O; Children's Oncology Group, Arcadia, CA., Rau RE; Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA.; Fred Hutch Cancer Center, University of Washington, Seattle, WA., Angiolillo AL; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC.; Department of Pediatrics and Clinical and Translational Oncology Program, George Washington University School of Medicine and Health Sciences, Washington, DC., McNeer JL; Huntsman Cancer Institute, Primary Children's Hospital, University of Utah, Salt Lake City, UT., Schore RJ; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC.; Department of Pediatrics and Clinical and Translational Oncology Program, George Washington University School of Medicine and Health Sciences, Washington, DC., Borowitz MJ; Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD., Wood B; Keck School of Medicine, University of Southern California, Los Angeles, CA.; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA., Raetz EA; Perlmutter Cancer Center, Division of Pediatric Hematology and Oncology, Department of Pediatrics, NYU Langone Health, New York, NY., Silverman LB; Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY., Winick NJ; University of Texas Southwestern Medical Center, Dallas, TX., Larsen EC; Maine Children's Cancer Program, Scarborough, ME., Carroll WL; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA., Winter SS; Cancer and Blood Disorders Program, Children's Minnesota, Minneapolis, MN., Dunsmore KP; Virginia Tech University, Roanoke, VA., Hunger SP; Department of Pediatrics and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Loh ML; Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA.; Fred Hutch Cancer Center, University of Washington, Seattle, WA. |
| Source: | Blood advances [Blood Adv] 2026 Jul 28; Vol. 10 (14), pp. 4923-4930. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
